Catalyst Wire Dossier Catalyst Wire Dossier

LM103 injection

LM103 · Suzhou BlueHorse Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LM103 injection, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours [EARLY_Phase 1]

See pricing